AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Roche’s new skin cancer drug now available in UK

 Uncategorized  Comments Off on Roche’s new skin cancer drug now available in UK
Aug 212013
 

AUGUST 20, 2013

Roche's new skin cancer drug now available in UK

UK patients with a certain type of skin cancer can now get access to Roche’s once-daily pill Erivedge following its launch in the country.

Erivedge（vismodegib）胶囊

Erivedge (vismodegib) is the first medicine available in the UK for the treatment of patients with symptomatic metastatic basal cell carcinoma (BCC) or locally advanced BCC that is unsuitable for surgery or radiotherapy.

http://www.pharmatimes.com/Article/13-08-20/Roche_s_new_skin_cancer_drug_now_available_in_UK.aspx

 

Erivedge（vismodegib）胶囊

Share

Curis has obtained the conditional approval for Erivedge (vismodegib) in EU

 Uncategorized  Comments Off on Curis has obtained the conditional approval for Erivedge (vismodegib) in EU
Jul 192013
 

VISMODEGIB

Oncology-focused drug development company Curis has obtained the conditional approval for Erivedge (vismodegib) to treat adult patients with symptomatic metastatic basal cell carcinoma (BCC) or locally advanced BCC inappropriate for surgery or radiotherapy in the European Union (EU)

http://regulatoryaffairs.pharmaceutical-business-review.com/news/curis-obtains-conditional-approval-of-erivedge-in-eu-170713

Vismodegib (trade name Erivedge) is a drug for the treatment of basal-cell carcinoma(BCC). The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. The drug is also undergoing clinical trials for metastatic colorectal cancer,small-cell lung cancer, advanced stomach cancer, pancreatic cancer, medulloblastomaand chondrosarcoma as of June 2011. The drug was developed by the biotechnology /pharmaceutical company Genentech, which is headquartered at South San Francisco, California, USA.

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: